|01-12-2019 07:40 AM CET - Health & Medicine||
Flu Vaccine, United States Market is expected to reach nearly US 3 Billion by 2024 | Seqirus, Sanofi Pasteur, GlaxoSmithKline(GSK)
Press release from: HTF Market Intelligence Consulting Pvt. Ltd.
HTF MI released a new market study on Flu Vaccine Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Flu Vaccine Forecast till 2024*. Some are the key players taken under coverage for this study are Seqirus, Sanofi Pasteur, GlaxoSmithKline(GSK).
Click to get Flu Vaccine Market Research Sample PDF Copy Here @: www.htfmarketreport.com/sample-report/1424385-flu-vaccine...
#Summary: United States flu vaccine market is expected to reach nearly US 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.
Long–term Growth Projection and Development:
• Sanofi to Acquire Protein Sciences Corporation
• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
• It is projected that GSK flu vaccine sales value will reach around US 1.5 Billion by 2024
• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine
“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.
Important Features that are under offering & key highlights of the report :
1) What all companies are currently profiled in the report?
Following are list of players that are currently profiled in the the report " Seqirus, Sanofi Pasteur, GlaxoSmithKline(GSK) "
** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.
2) Can we add or profiled new company as per our need?
Yes, we can add or profile new company as per client need in the report. Final confirmation to be provided by research team depending upon the difficulty of survey.
** Data availability will be confirmed by research in case of privately held company. Upto 3 players can be added at no added cost.
3) What all regional segmentation covered? Can specific country of interest be added?
Currently, research report gives special attention and focus on following regions:
North America, Europe, Asia-Pacific, South America, Middle East and Africa
** One country of specific interest can be included at no added cost. For inclusion of more regional segment quote may vary.
4) Can inclusion of additional Segmentation / Market breakdown is possible?
Yes, inclusion of additional segmentation / Market breakdown is possible subject to data availability and difficulty of survey. However a detailed requirement needs to be shared with our research before giving final confirmation to client.
** Depending upon the requirement the deliverable time and quote will vary.
Enquire for customization in Report @ www.htfmarketreport.com/enquiry-before-buy/1424385-flu-va...
Key Topics Covered in the Report
• Market Overview: United States Flu Vaccine Market (2010 - 2024)
• United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024)
• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
• Reimbursement & Regulatory System in the US Flu Vaccine Market
• Mergers, Acquisitions, Key Agreements & Collaborations
• Promising Flu Vaccine in Clinical Development
• Flu Vaccine Clinical Trial Insights by Phase, Company & Country
• Key Drivers and Inhibitors of the US Flu Vaccine Market
• Key Companies Analysis
Major Flu Vaccines Covered Under This Report Are:
Fluzone High–Dose, Fluzone Quadrivalent, Intradermal (ID) Trivalent , Vaxigrip , Fluarix Quadrivalent , Flulaval Quadrivalent, Flucelvax Quadrivalent , Afluria Quadrivalent, Agrippal, Fluad , Fluvirin, Fluvax
The key players are highly focusing innovation in production technologies to improve efficiency and shelf life. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies. Company profile section of players such as Seqirus, Sanofi Pasteur, GlaxoSmithKline(GSK) includes its basic information like legal name, website, headquarters, its market position, historical background and top 5 closest competitors by Market capitalization / revenue along with contact information. Each player/ manufacturer revenue figures, growth rate and gross profit margin is provided in easy to understand tabular format for past 5 years and a separate section on recent development like mergers, acquisition or any new product/service launch etc.
Buy Full Copy Flu Vaccine Report 2018 @ www.htfmarketreport.com/buy-now?format=1&report=1424385
In this study, the years considered to estimate the market size of Flu Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
Key Stakeholders/Global Reports:
Flu Vaccine Manufacturers
Flu Vaccine Distributors/Traders/Wholesalers
Flu Vaccine Subcomponent Manufacturers
Browse for Full Report at @: www.htfmarketreport.com/reports/1424385-flu-vaccine-marke...
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
This release was published on openPR.
News-ID: 1492373 • Views: 2016More releases